Mojgan Sheikhpour

Dr. Mojgan Sheikhpour


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Nanotechnology, Science and Applications
Verified
Journal Article
Open access
PDF file
MSMojgan Sheikhpour
Mojgan Sheikhpour
MAMohadeseh Arabi
Mohadeseh Arabi
AKAlibakhsh Kasaeian
Alibakhsh Kasaeian
ARAli Rokn Rabei
Ali Rokn Rabei
ZTZahra Taherian
Zahra Taherian
Recently, suspensions of several nanoparticles or nanocomposites have attained a vast field of application in biomedical research works in some specified conditions and clinical trials. These valuable suspensions, which allow the nanoparticles to disperse and act in homogenous and stable media, are named as nanofluids. Several studies have introduced the advantages of nanofluids in biomedical approaches in different fields. Few review articles have been reported for presenting an overview of the wide biomedical applications of nanofluids, such as diagnosis and therapy. The review is focused on nanosuspensions, as the nanofluids with solid particles. Major applications are focused on nanosuspension, which is the main type of nanofluids. So, concise content about major biomedical applications of nanofluids in drug delivery systems, imaging, and antibacterial activities is presented in this paper. For example, applying magnetic nanofluid systems is an important route for targeted drug delivery, hyperthermia, and differential diagnosis. Also, nanofluids could be used as a potential antibacterial agent to overcome antibiotic resistance. This study could be useful for presenting the novel and applicable methods for success in current medical practice.

1 May 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
MSMojgan Sheikhpour
Mojgan Sheikhpour
LBLeila Barani
Leila Barani
AKAlibakhsh Kasaeian
Alibakhsh Kasaeian

1 October 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
SDSorour Derakhti
Sorour Derakhti
SSSeyed Hamid Safiabadi-Tali
Seyed Hamid Safiabadi-Tali
GAGhasem Amoabediny
Ghasem Amoabediny
MSMojgan Sheikhpour
Mojgan Sheikhpour

7 May 2019 in Biotechnology Progress
Verified
Journal Article
Closed access
PDF file
PFParisa Farrokh
Parisa Farrokh
MSMojgan Sheikhpour
Mojgan Sheikhpour
AKAlibakhsh Kasaeian
Alibakhsh Kasaeian
HAHassan Asadi
Hassan Asadi
RBRoya Bavandi
Roya Bavandi

1 July 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MSMojgan Sheikhpour
Mojgan Sheikhpour
AGAli Golbabaie
Ali Golbabaie
AKAlibakhsh Kasaeian
Alibakhsh Kasaeian

29 March 2021 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
MSMojgan Sheikhpour
Mojgan Sheikhpour
MMMobina Maleki
Mobina Maleki
MVMaryam Ebrahimi Vargoorani
Maryam Ebrahimi Vargoorani
VAVahid Amiri
Vahid Amiri
Several studies show that childhood and adulthood asthma and its symptoms can be modulated through epigenetic modifications. Epigenetic changes are inheritable modifications that can modify the gene expression without changing the DNA sequence. The most common epigenetic alternations consist of DNA methylation and histone modifications. How these changes lead to asthmatic phenotype or promote the asthma features, in particular by immune pathways regulation, is an understudied topic. Since external effects, like exposure to tobacco smoke, air pollution, and drugs, influence both asthma development and the epigenome, elucidating the role of epigenetic changes in asthma is of great importance. This review presents available evidence on the epigenetic process that drives asthma genes and pathways, with a particular focus on DNA methylation, histone methylation, and acetylation. We gathered and assessed studies conducted in this field over the past two decades. Our study examined asthma in different aspects and also shed light on the limitations and the important factors involved in the outcomes of the studies. To date, most of the studies in this area have been carried out on DNA methylation. Therefore, the need for diagnostic and therapeutic applications through this molecular process calls for more research on the histone modifications in this disease.